Copyright
©The Author(s) 2022.
World J Gastrointest Endosc. Jun 16, 2022; 14(6): 402-415
Published online Jun 16, 2022. doi: 10.4253/wjge.v14.i6.402
Published online Jun 16, 2022. doi: 10.4253/wjge.v14.i6.402
Table 11 Follow-up data of studied patients
| Follow-up | Stationary | Regressive | No-recurrence | Progressive | Died |
| Pancreatic pseudocyst (n = 30) | 27 (35.5%) | 3 (3.9%) | 0 | 0 | 0 |
| Pancreatic pseudocyst with WOPN (n = 1) | 0 | 0 | 1 (1.3%) | 0 | 0 |
| Serous cystadenoma (n = 13) | 12 (15.7%) | 0 | 1 (1.3%) | 0 | 0 |
| Mucinous cystadenoma (n = 10) | 9 | 0 | 1 (1.3%) | 0 | 0 |
| Mucinous cystadenocarcinoma (n = 1) | 0 | 0 | 0 | 1 | 0 |
| IPMN (high grade dysplasia) (n = 10) | 3 | 0 | 7 | 0 | 0 |
| IPMN (low grade dysplasia) (n = 6) | 6 | 0 | 0 | 0 | 0 |
| Pancreatic adenocarcinoma (n = 4) | 0 | 0 | 2 (2.6%) | 0 | 2 (2.6%) |
| Cystic lymphangioma (n = 1) | 1 (1.3%) | 0 | 0 | 0 | 0 |
| Total (n = 76) | 40 (52.6%) | 3 (3.9%) | 5 (6.5%) | 0 | 2 (2.6%) |
- Citation: Okasha HH, Abdellatef A, Elkholy S, Mogawer MS, Yosry A, Elserafy M, Medhat E, Khalaf H, Fouad M, Elbaz T, Ramadan A, Behiry ME, Y William K, Habib G, Kaddah M, Abdel-Hamid H, Abou-Elmagd A, Galal A, Abbas WA, Altonbary AY, El-Ansary M, Abdou AE, Haggag H, Abdellah TA, Elfeki MA, Faheem HA, Khattab HM, El-Ansary M, Beshir S, El-Nady M. Role of endoscopic ultrasound and cyst fluid tumor markers in diagnosis of pancreatic cystic lesions. World J Gastrointest Endosc 2022; 14(6): 402-415
- URL: https://www.wjgnet.com/1948-5190/full/v14/i6/402.htm
- DOI: https://dx.doi.org/10.4253/wjge.v14.i6.402